Concepts (52)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Microglia | 3 | 2022 | 11 | 1.630 |
Why?
|
| Brain Ischemia | 2 | 2022 | 8 | 1.010 |
Why?
|
| Sulfonylurea Compounds | 1 | 2022 | 1 | 0.800 |
Why?
|
| Cell Hypoxia | 1 | 2021 | 1 | 0.790 |
Why?
|
| Diterpenes | 1 | 2021 | 3 | 0.790 |
Why?
|
| Brain Injuries | 1 | 2022 | 31 | 0.780 |
Why?
|
| Neuroprotective Agents | 1 | 2021 | 13 | 0.770 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2022 | 39 | 0.760 |
Why?
|
| Inflammation | 1 | 2022 | 59 | 0.760 |
Why?
|
| Neurons | 1 | 2021 | 131 | 0.690 |
Why?
|
| Animals | 6 | 2024 | 1798 | 0.380 |
Why?
|
| Cells, Cultured | 2 | 2022 | 134 | 0.380 |
Why?
|
| Mice | 5 | 2024 | 716 | 0.320 |
Why?
|
| Infarction, Middle Cerebral Artery | 2 | 2022 | 3 | 0.260 |
Why?
|
| Acid Ceramidase | 1 | 2024 | 6 | 0.240 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2024 | 9 | 0.240 |
Why?
|
| Lipid Metabolism | 1 | 2024 | 14 | 0.240 |
Why?
|
| Liver Cirrhosis | 1 | 2024 | 11 | 0.240 |
Why?
|
| Homeostasis | 1 | 2024 | 29 | 0.240 |
Why?
|
| Liver | 1 | 2024 | 50 | 0.230 |
Why?
|
| Encephalitis | 1 | 2022 | 1 | 0.210 |
Why?
|
| Sialic Acid Binding Immunoglobulin-like Lectins | 1 | 2022 | 1 | 0.210 |
Why?
|
| Receptors, Prostaglandin E, EP2 Subtype | 1 | 2022 | 1 | 0.210 |
Why?
|
| Tight Junction Proteins | 1 | 2022 | 4 | 0.200 |
Why?
|
| Endothelium | 1 | 2022 | 4 | 0.200 |
Why?
|
| Neuroblastoma | 1 | 2022 | 12 | 0.200 |
Why?
|
| Blood-Brain Barrier | 1 | 2022 | 7 | 0.200 |
Why?
|
| Mammals | 1 | 2022 | 18 | 0.200 |
Why?
|
| DNA-Binding Proteins | 1 | 2022 | 23 | 0.200 |
Why?
|
| Nervous System Diseases | 1 | 2022 | 5 | 0.200 |
Why?
|
| Endothelial Cells | 1 | 2022 | 48 | 0.200 |
Why?
|
| Structure-Activity Relationship | 1 | 2022 | 44 | 0.200 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2022 | 53 | 0.200 |
Why?
|
| Glucose | 1 | 2021 | 13 | 0.200 |
Why?
|
| Molecular Structure | 1 | 2022 | 85 | 0.190 |
Why?
|
| Models, Molecular | 1 | 2022 | 84 | 0.190 |
Why?
|
| Signal Transduction | 1 | 2022 | 223 | 0.170 |
Why?
|
| Brain | 1 | 2022 | 276 | 0.160 |
Why?
|
| Humans | 3 | 2024 | 5357 | 0.120 |
Why?
|
| Mice, Knockout | 2 | 2024 | 141 | 0.110 |
Why?
|
| Dinoprostone | 2 | 2022 | 7 | 0.100 |
Why?
|
| Hepatocytes | 1 | 2024 | 12 | 0.060 |
Why?
|
| Diet, High-Fat | 1 | 2024 | 35 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 1 | 2024 | 195 | 0.060 |
Why?
|
| Mice, Nude | 1 | 2022 | 24 | 0.050 |
Why?
|
| Lipopolysaccharides | 1 | 2022 | 15 | 0.050 |
Why?
|
| Tumor Microenvironment | 1 | 2022 | 27 | 0.050 |
Why?
|
| Prostaglandin-E Synthases | 1 | 2022 | 1 | 0.050 |
Why?
|
| Interleukin-6 | 1 | 2022 | 9 | 0.050 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2022 | 14 | 0.050 |
Why?
|
| Cytokines | 1 | 2022 | 36 | 0.050 |
Why?
|
| Male | 1 | 2024 | 2704 | 0.030 |
Why?
|